Saframycine G
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
Saframycin G has the effect of anti-Gram-positive bacteria. Saframycin G has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.03 μM[1].
92569-02-3
12352005
Bacterial
Anti-infection
Cancer; Infection
CC(C(NC[C@@H]1N2[C@](CC3=C1C(C(OC)=C(C3=O)C)=O)([H])[C@@]4([H])C5=C(C(C(C)=C(C5=O)OC)=O)[C@@H]([C@@](N4C)([H])[C@@H]2C#N)O)=O)=O
C29H30N4O9
578.57
[1]N Saito, et al. Synthesis of saframycins. X. Transformation of (-) -saframycin A to (-) -saframycin Mx type compound with the structure proposed for saframycin E. Chem Pharm Bull (Tokyo) . 1995 May;43 (5) :777-82.
Room temperature
http://file.medchemexpress.com/batch_PDF/HY-N14515/
Natural Products
No Development Reported
Beschrijving
Saframycin G has the effect of anti-Gram-positive bacteria. Saframycin G has the effect of inhibiting mouse lymphocyte L-1210 with an ID50 of 0.03 μM[1].
Specificaties
Recent bekeken producten
Purified Diphtheria Toxoid protein (antigen grade)
DTOX15-N-500
100 µg
Hepatitis A Virus
MBS320138-01
0.1 mg
Hepatitis A Virus
506273
1 mg
MIN6 Cells
T1338
1x106 cells / 1.0 mL
Human Mast Cells - Dermis
ABC-TC105W
1 Vial
CYP1A2 Inhibitor Screening Assay
MA-0389
200 Well
Culture Medium for Immortalized Human Parathyroid Cells
AFG-ELL-2645-01
100 mL
Immortalized Human Parathyroid Cells
AFG-ELL-2055
> 1x 10^6 Cells / Vial
Recent gezochte producten
Microspheres PS, S/DVB 1.00µm, PS04N
PS04001-0.5
0.5 g
Microspheres PS, S/DVB 1.00µm, PS04N
PS04001-1.5
1.5 g
Microspheres PS, S/DVB 1.00µm, PS04N
PS04001-5.0
5.0 g
Microspheres PS, S/DVB 10.00µm, PS07N
PS07001-5.0
5.0 g
Microspheres PS, S/DVB 10.00µm, PS07N
PS07001-0.5
0.5 g
Microspheres PS, S/DVB 10.00µm, PS07N
PS07001-1.5
1.5 g
Microspheres PS, S/DVB 10.00µm, PS07N
PS07001-1.0
1.0 g
Microspheres PS, S/DVB 1.00µm, PS04N
PS04001-1.0
1.0 g